Skip to main content
S. 2817 116th Congress Senate

End Price Gouging for Insulin Act

Official title: A bill to require the Secretary of Health and Human Services to establish an annual reference price for insulin products for purposes of Federal health programs, and for other purposes.

Introduced: November 7, 2019 Introduced by: Jeff Merkley Democratic · Oregon See on congress.gov
Health AsiaAustraliaCanadaDepartment of Health and Human Services
More subjectsShow fewer subjects
EuropeExecutive agency funding and structureFranceGermanyHealth care costs and insuranceHealth programs administration and fundingIndian social and development programsInflation and pricesItalyJapanMedicaidMedical researchMedicareNetherlandsNorth AmericaPrescription drugsResearch administration and fundingResearch and developmentRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 7, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Nov 7, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 7, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)

 Plain-English summary Congressional Research Service

End Price Gouging for Insulin Act

This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.

 Related & companion bills 1
  • HR 5364 Identical bill End Price Gouging for Insulin Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Durbin, Richard J.
Illinois · Nov 7, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2817: End Price Gouging for Insulin Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2817/
MLA
"S. 2817: End Price Gouging for Insulin Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2817/.
Bluebook (legal)
S. 2817, 116th Cong. (2026), https://openamerica.io/bill/116-S-2817/.
Markdown link
[S. 2817: End Price Gouging for Insulin Act](https://openamerica.io/bill/116-S-2817/)
Report a problem